US 11913012
Cardiac cell reprogramming with myocardin and ASCL1
granted A61KA61K38/1719A61K48/005
Quick answer
US patent 11913012 (Cardiac cell reprogramming with myocardin and ASCL1) held by Tenaya Therapeutics, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tenaya Therapeutics, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/1719, A61K48/005